NCT02580552 2020-11-23Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLLmiRagen Therapeutics, Inc.Phase 1 Completed66 enrolled